Chapter 3: Honey Bee Venom as a Potential Treatment in Aggressive Triple Negative and HER2-Enriched Breast Cancer
Authors: Christine Nguyen, Hanna Given, Ha Yeon Kim and Tom Borrillo
Duffy C., et al. (2020). Honeybee venom and melittin suppress growth factor receptor activation in HER2-enriched and triple-negative breast cancer. NPJ Precision Oncology, 4(24), 1-24. doi:10.1038/s41698-020-00129-0